Skip to content
value.today

Immuron Ltd: peers

Change the peers

Immuron Ltd beside the 7 companies most like it by industry, size and country: every figure with its date and source, its rank in the group and its percentile in its sector and country.

Immuron Ltd, Memphasys Limited, Vectus Biosystems Limited, Medlab Clinical Limited, Acrux Limited, Bio-Gene Technology Limited, AdAlta Limited: the market cap on file is more than 60 days old or a last known value (no market-data feed for their exchanges yet), so their valuation multiples and yields are shown but not ranked.

Side by side#

Every figure with its fiscal year or date and its source. Switch to each company's rank in the group, or its percentile in its sector or country. How ranks are worked out.

Immuron Ltd, Propanc Biopharma, Inc., Memphasys Limited, Vectus Biosystems Limited, Medlab Clinical Limited, Acrux Limited, Bio-Gene Technology Limited, AdAlta Limited side by side: each figure with its period and source, its rank among these companies and its percentile in the company's sector and country
MeasureImmuron Ltdbase
IMRN · 🇦🇺 AU
Percentile in Healthcare
Percentile in Australia
Propanc Biopharma, Inc.
PPCB · 🇦🇺 AU
Percentile in Healthcare
Percentile in Australia
Memphasys Limited
MEM.AX · 🇦🇺 AU
Percentile in Healthcare
Percentile in Australia
Vectus Biosystems Limited
VBS.AX · 🇦🇺 AU
Percentile in Healthcare
Percentile in Australia
Medlab Clinical Limited
MDC.AX · 🇦🇺 AU
Percentile in Healthcare
Percentile in Australia
Acrux Limited
ACR.AX · 🇦🇺 AU
Percentile in Healthcare
Percentile in Australia
Bio-Gene Technology Limited
BGT.AX · 🇦🇺 AU
Percentile in Healthcare
Percentile in Australia
AdAlta Limited
1AD.AX · 🇦🇺 AU
Percentile in Healthcare
Percentile in Australia
Group median
Size
Market cap (Better neither way: ranked highest first)$9 MAug 1, 2026 · Market data5th of 8$13 MOct 29, 2026 · Market data1st of 8$9 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one5th of 8$10 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one2nd of 8$10 Mlast known, Dec 25, 2022 · Market dataLast known value: no current one2nd of 8$10 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one2nd of 8$8 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one7th of 8$8 Mlast known, Jan 5, 2024 · Market dataLast known value: no current one7th of 8$10 M8 ranked
Revenue (Better neither way: ranked highest first)$5 MFY2025 · SEConly one with it——————————————$5 M—
Net income (Higher is better)$-3 MFY2025 · SEC1st of 2$-19 MFY2026 · SEC2nd of 2————————————$-11 M2 ranked
Growth
Revenue growth (Higher is better)+47.0%FY2025 · SEConly one with it83rd72nd————————————————————————————+47.0%—
Revenue growth, 3 years a year (Higher is better)+103.5%FY2025 · SEConly one with it95th95th————————————————————————————+103.5%—
Margins and returns
Gross margin (Higher is better)65.5%FY2025 · SEConly one with it60th—————————————————————————————65.5%—
Operating margin (Higher is better)-73.3%FY2025 · SEConly one with it26th—————————————————————————————-73.3%—
Net margin (Higher is better)-71.6%FY2025 · SEConly one with it27th38th————————————————————————————-71.6%—
Return on equity (Higher is better)-49.2%FY2025 · SEC1st of 244th32nd-161.8%FY2026 · SEC2nd of 214th2nd————————————————————————-105.5%2 ranked
Valuation
Price to sales (Better neither way: ranked highest first)1.9×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price——————————————————————————————
Price to book (Better neither way: ranked highest first)1.7×price Aug 1, 2026 · Market datanot ranked: old priceold priceold price1.4×price Oct 29, 2026 · Market dataonly one with it28th—————————————————————————1.4×—
Free cash flow yield (Higher is better)-42.8%price Aug 1, 2026 · Market datanot ranked: old priceold priceold price-42.5%price Oct 29, 2026 · Market dataonly one with it21st—————————————————————————-42.5%—
Financial strength
Interest cover (Higher is better)————-42.3×FY2026 · SEConly one with it23rd—————————————————————————-42.3×—
Scorecard
Scorecard (Higher is better)7 of 15FY2025 · Scorecard1st of 22 of 12FY2026 · Scorecard2nd of 2————————————32% passed2 ranked
Valuation checks (Higher is better)——1 of 4FY2026 · Scorecardonly one with it————————————25% passed—
Growth checks (Higher is better)4 of 6FY2025 · Scorecard1st of 20 of 2FY2026 · Scorecard2nd of 2————————————33% passed2 ranked
Profitability checks (Higher is better)1 of 5FY2025 · Scorecard1st of 20 of 3FY2026 · Scorecard2nd of 2————————————10% passed2 ranked
Financial health checks (Higher is better)1 of 3FY2025 · Scorecard1st of 21 of 3FY2026 · Scorecard1st of 2————————————33% passed2 ranked
Shareholder returns checks (Higher is better)1 of 1FY2025 · Scorecardonly one with it——————————————100% passed—
Ownership
Held by institutions (Better neither way: ranked highest first)1.9%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 21.2%2026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 2————————————1.6%2 ranked
Institutions holding (Better neither way: ranked highest first)82026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in1st of 252026-Q3 · 13FStill being filed: 98% of the filers of the quarter before are in2nd of 2————————————72 ranked

Under each figure: its fiscal year, quarter or date, and its source. ↑ higher is better, ↓ lower is better, · better neither way (ranked highest first). Ranks count only the companies with the figure; percentiles place each company among all the companies of its own sector and country with the figure (ten or more needed).

† The market cap behind this figure is more than 60 days old (no market-data feed for that exchange yet): it is shown but not ranked or given a percentile.

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Editors = The company's annual report, entered by value.today editors; Wikidata = Wikidata, citing the annual report; Scorecard = value.today scorecard: thirty checks on the company's statements, worked out daily; 13F = SEC Form 13F holdings reports; SEC = Dividends declared per share in SEC 10-Q and 10-K filings; Profile = The company's latest reported headcount; Market data = Immuron Ltd: How market caps are worked out; Propanc Biopharma, Inc.: How market caps are worked out; Memphasys Limited: How market caps are worked out; Vectus Biosystems Limited: How market caps are worked out; Medlab Clinical Limited: How market caps are worked out; Acrux Limited: How market caps are worked out; Bio-Gene Technology Limited: How market caps are worked out; AdAlta Limited: How market caps are worked out.

Where each stands in its sector and country: Operating margin#

The dot is the company; the line runs from the 10th to the 90th percentile of all the companies of its sector (or country) with the figure, the box holds the middle half and the tick is the median. Each company's newest fiscal year; figures that divide by the market value only with a market cap at most 60 days old. How percentiles are worked out.

Operating margin: each company's figure and its percentile in its sector and its country
CompanyOperating marginIn its sectorIn its country
Immuron Ltd-73.3%FY2025
26th percentile in Healthcaremedian -7.7%, 674 companies
—
Propanc Biopharma, Inc.———
Memphasys Limited———
Vectus Biosystems Limited———
Medlab Clinical Limited———
Acrux Limited———
Bio-Gene Technology Limited———
AdAlta Limited———

Revenue by fiscal year, and the rank in the group#

Revenue of the fiscal year. US dollars at each year's exchange rate; fiscal years as each company names them. Ranks: 1st is the highest (better neither way).

Revenue

$0 M$1 M$2 M$4 M$5 M201720182019202020212022202320242025Immuron Ltd $5 M

Rank in the group

Ranks need two fiscal years with the figure for at least two of these companies.

Revenue by fiscal year with each company's rank in the group and the source of each figure
Fiscal yearImmuron LtdPropanc Biopharma, Inc.Memphasys LimitedVectus Biosystems LimitedMedlab Clinical LimitedAcrux LimitedBio-Gene Technology LimitedAdAlta Limited
2025$5 MSEC———————
2024$3 MSEC———————
2023$1 MSEC———————
2022$1 MSEC———————
2021$0 MSEC———————
2020$2 MSEC———————
2019$1 MSEC———————
2018$1 MSEC———————
2017$1 MSEC———————
2016$1 MSEC———————

Sources: SEC = SEC annual reports (10-K, 20-F, 40-F); ESEF = ESEF annual reports (European and UK listed companies); Ed. = The company's annual report, entered by value.today editors; WD = Wikidata, citing the annual report; Cap = value.today market caps (the last of each calendar year). The small ordinal is the rank in the group that year. Hover a figure for its fiscal year end.

Suggested peers of Immuron Ltd#

Companies of the same industry, within a hundred times its size (market cap), scored out of 100 for industry, size, country and figures on file. How peers are suggested.

  • Propanc Biopharma, Inc.PPCB · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $13 M market cap against $9 M · Same country: Australia · Ratios of the last two fiscal years on file
    Market cap $13 M (Oct 29, 2026)
    97 of 100 (industry or sector 50 + size 27 + country 15 + figures on file 5)
    In the group
  • Memphasys LimitedMEM.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $9 M market cap against $9 M · Same country: Australia
    Market cap $9 M (last known, Jan 5, 2024)
    95 of 100 (industry or sector 50 + size 30 + country 15)
    In the group
  • Vectus Biosystems LimitedVBS.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $10 M market cap against $9 M · Same country: Australia
    Market cap $10 M (last known, Jan 5, 2024)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • Medlab Clinical LimitedMDC.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $10 M market cap against $9 M · Same country: Australia
    Market cap $10 M (last known, Dec 25, 2022)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • Acrux LimitedACR.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $10 M market cap against $9 M · Same country: Australia
    Market cap $10 M (last known, Jan 5, 2024)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • Bio-Gene Technology LimitedBGT.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $8 M market cap against $9 M · Same country: Australia
    Market cap $8 M (last known, Jan 5, 2024)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • AdAlta Limited1AD.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $8 M market cap against $9 M · Same country: Australia
    Market cap $8 M (last known, Jan 5, 2024)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    In the group
  • Benitec Biopharma Inc.BNTC · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $8 M market cap against $9 M · Same country: Australia
    Market cap $8 M (last known, Jan 5, 2024)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    + Add
  • Radiopharm Theranostics LimitedRAD.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $23 M market cap against $9 M · Same country: Australia · Ratios of the last two fiscal years on file
    Market cap $23 M (last known, Jan 5, 2024) · revenue $4 M (year to June 2025)
    94 of 100 (industry or sector 50 + size 24 + country 15 + figures on file 5)
    + Add
  • Bionomics LimitedBNOX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $11 M market cap against $9 M · Same country: Australia
    Market cap $11 M (last known, Jan 5, 2024)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    + Add
  • Amplia Therapeutics LimitedATX.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $11 M market cap against $9 M · Same country: Australia
    Market cap $11 M (last known, Jan 5, 2024)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    + Add
  • Patrys LimitedPAB.AX · 🇦🇺 Australia
    Same industry: Biotechnology · Similar size: $11 M market cap against $9 M · Same country: Australia
    Market cap $11 M (last known, Jan 5, 2024)
    94 of 100 (industry or sector 50 + size 29 + country 15)
    + Add

Any figure over the years, other peers or a saved group: open this group in the peer workspace.